All you have to do is to visit the homepage of the Journal of Pharmaceutical Research and Innovation (JPRI) journal website and click on the 'Submit Article or Online paper submission' option. Subsequently, a submission portal where you can enter in relevant details and attach your manuscript will open.
Please check the payment page for details, Click here
Yes, the Journal of Pharmaceutical Research and Innovation (JPRI) journal is an open-access journal.
Yes, Journal of Pharmaceutical Research and Innovation (JPRI) is an open-access journal.
Yes, Journal of Pharmaceutical Research and Innovation (JPRI) is a double-blind peer-reviewed journal.
Journal of Pharmaceutical Research and Innovation (JPRI) is a bi-annual journal, meaning it publishes two issues every year.
Please check the payment page for details, Click here
Yes, authors are allowed to submit more than one manuscript for a single issue of the Journal of Pharmaceutical Research and Innovation (JPRI) journal, as long as each of these manuscripts is different from each other.
Authors can submit their manuscripts by clicking on the 'Online Paper Submission' tab on the Journal of Pharmaceutical Research and Innovation (JPRI) journal website or email them to editor@technoarete.org.
The Journal of Pharmaceutical Research and Innovation (JPRI) journal makes use of the Turnitin application to carry out comprehensive and thorough plagiarism checks for all suggested manuscripts to verify their originality and authenticity.
The Journal of Pharmaceutical Research and Innovation (JPRI) journal is committed to ensuring faster peer review times than any other journal, while also ensuring the sustenance and preservation of our high standards of quality and research integrity. On average, it takes about four week or less to complete the entire peer-review process for an entire manuscript.
Yes! One can download the manuscript template prepared by the Journal of Pharmaceutical Research and Innovation (JPRI) journal to serve as a guide for those who wish to submit manuscripts, by clicking on the 'Manuscript Template -Download' option under the 'Instruction for Authors' section in the left-hand side panel on the Journal of Pharmaceutical Research and Innovation (JPRI) journal website.
All manuscripts submitted to the Journal of Pharmaceutical Research and Innovation (JPRI) journal must either be in the Microsoft Word formats.
An email acknowledging the receipt of your submission will be sent out within 12 to 24 hours of you submitting your manuscript to the Journal of Pharmaceutical Research and Innovation (JPRI) journal.
Although this is purely dependant on the number of manuscripts that are in queue for reviewal, it takes around two weeks on average for the entire review process to be completed.
To get to know about the scope as well as the discipline of specialization of the Journal of Pharmaceutical Research and Innovation (JPRI) journal, click on the 'Aim and Scope' option under the 'About the Journal' tab on the Journal of Pharmaceutical Research and Innovation (JPRI) journal website.
No! It is mandatory for authors to send in the entire manuscripts of their research works, without any missing parts, while submitting them to the Journal of Pharmaceutical Research and Innovation (JPRI) journal.
The Paper ID is a unique identification code that is given for every manuscript that is submitted to Journal of Pharmaceutical Research and Innovation (JPRI). Authors are urged to specify the Paper ID of their manuscript in all of their communications with Journal of Pharmaceutical Research and Innovation (JPRI) to make the identifying of their manuscripts easier.
No!
Unless and until a submitted manuscript has been rejected by the reviewing committee of Journal of Pharmaceutical Research and Innovation (JPRI), an author is bound by an agreement that the same manuscript has not been submitted and will not be published by any journal other than Journal of Pharmaceutical Research and Innovation (JPRI).
At the Journal of Pharmaceutical Research and Innovation (JPRI) journal, we undertake a double-blind peer-reviewing process. As soon as manuscripts are received, we sent them to members of the reviewing committee for reviewing, after details such as -
have been removed, in order to facilitate thoroughly impartial and merit-based reviewal.
For every manuscript that is submitted, a minimum of 4 pages and a maximum of 20 pages are allowed.
Yes, there are! Please check out the 'Instruction for Authors' section on the left-hand side panel, for all guidelines and specifications.
To view the Terms & Conditions of the Journal of Pharmaceutical Research and Innovation (JPRI) journal, click on the ‘Terms & Conditions’ option, under the ‘About Journal’ section, at the bottom of every page of the Journal of Pharmaceutical Research and Innovation (JPRI) journal website.
Feel free to mail any inquiries, feedback or recommendations that you might have, to editor@technoarete.org. We'd be more than happy to resolve your queries and take stock of your suggestions.
After passing through the initial screening process, manuscripts will be sent for two or three further reviews (for a thorough evaluation of the content). Under normal circumstances, the entire process is completed in a matter of two to three weeks.
Feel free to email the title of your paper and paper ID to the following address - editor@technoarete.org. A representative of the editorial committee at Journal of Pharmaceutical Research and Innovation (JPRI) will respond with the status of your paper, within 24 hours.
Simply click on the 'Instruction for Authors' option on the left-hand side panel, and choose the 'Manuscript Template -Download' option to download the template. This document also includes all formatting and styling specifications that are to be followed.
Copyright forms secure the rights and interests of both authors and publishers. As part of the agreement, authors are mandated to hand over the exclusive license of their work to the publisher (in this case the Journal of Pharmaceutical Research and Innovation (JPRI) journal). In accordance with its open-access policy, Journal of Pharmaceutical Research and Innovation (JPRI) can publish, circulate, present and preserve manuscripts as it sees fit.
The Journal of Pharmaceutical Research and Innovation (JPRI) journal accepts any number of manuscripts from a single author as long as each of the submitted manuscripts is entirely different from each other and completely unique.
If you aren't quite sure about which of your manuscripts are fit for publication in the Journal of Pharmaceutical Research and Innovation (JPRI) journal, you might want to take a look at our objective, aim, and scope, to get an idea of the sort of research papers and articles we publish.
The Journal of Pharmaceutical Research and Innovation (JPRI) journal accepts and publishes a wide range of academic and scholarly work including research papers/articles, review pieces/articles, case reports/studies, etc.
Being a brand new journal, Journal of Pharmaceutical Research and Innovation (JPRI) does not have any impact factor data to present. at the moment. The impact factor value of a journal is usually a representation of the average number of citations of the works published therein, in articles/papers published by other journals recently, over the past two years.
Journal of Pharmaceutical Research and Innovation (JPRI) will make this data available as soon as the stipulated period has completed and accurate data has been compiled.